Foster Dykema Cabot & Partners’s Merck MRK Stock Holding History

Foster Dykema Cabot & Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.04M	Sell	8,626 -234	-3%	-$27K	0.07%	47
2025 Q4	$940K	Sell	8,860 -1,337	-13%	-$126K	0.06%	51
2025 Q3	$864K	Buy	10,197 +779	+8%	+$64.2K	0.06%	60
2025 Q2	$753K	Hold	9,418	–	–	0.05%	62
2025 Q1	$853K	Sell	9,418 -2,481	-21%	-$232K	0.07%	49
2024 Q4	$1.19M	Sell	11,899 -331	-3%	-$34.1K	0.09%	47
2024 Q3	$1.4M	Buy	12,230 +2,681	+28%	+$319K	0.12%	40
2024 Q2	$1.19M	Sell	9,549 -100	-1%	-$12.9K	0.11%	39
2024 Q1	$1.28M	Buy	9,649 +850	+10%	+$105K	0.12%	39
2023 Q4	$966K	Buy	+8,799	New	+$913K	0.1%	42

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Foster Dykema Cabot & Partners's MRK Position: Q1 2026 in Review

Foster Dykema Cabot & Partners reduced its Merck (MRK) stake by 2.6% in Q1 2026, selling an estimated $27K and leaving 8,626 shares worth $1.04M. The position accounts for 0.07% of the portfolio, ranked #47.

Foster Dykema Cabot & Partners first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.4M in Q3 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Foster Dykema Cabot & Partners held 8,626 shares of Merck worth $1.04M as of Q1 2026.
Foster Dykema Cabot & Partners sold 234 Merck shares in Q1 2026, an estimated $27K.
Merck made up 0.07% of Foster Dykema Cabot & Partners's portfolio in Q1 2026, its #47 holding.
Foster Dykema Cabot & Partners first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
Foster Dykema Cabot & Partners's Merck position peaked at $1.4M in Q3 2024.
3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q1 2026, filed 14 May 2026.